COPS5 (Jab1) Protein Increases β Site Processing of Amyloid Precursor Protein and Amyloid β Peptide Generation by Stabilizing RanBP9 Protein Levels*

Background: Increased generation of toxic amyloid β peptide (Aβ) in the brain is central to the pathogenesis of Alzheimer's disease (AD). Results: COPS5 (Jab1) is a novel RanBP9-interacting protein that robustly increases Aβ generation Conclusion: COPS5 increases Aβ generation by stabilizing RanBP9 protein levels. Significance: Lowering COPS5 levels may be an effective therapeutic approach for AD. Increased processing of amyloid precursor protein (APP) and accumulation of neurotoxic amyloid β peptide (Aβ) in the brain is central to the pathogenesis of Alzheimer's disease (AD). Therefore, the identification of molecules that regulate Aβ generation is crucial for future therapeutic approaches for AD. We demonstrated previously that RanBP9 regulates Aβ generation in a number of cell lines and primary neuronal cultures by forming tripartite protein complexes with APP, low-density lipoprotein-related protein, and BACE1, consequently leading to increased amyloid plaque burden in the brain. RanBP9 is a scaffold protein that exists and functions in multiprotein complexes. To identify other proteins that may bind RanBP9 and regulate Aβ levels, we used a two-hybrid analysis against a human brain cDNA library and identified COPS5 as a novel RanBP9-interacting protein. This interaction was confirmed by coimmunoprecipitation experiments in both neuronal and non-neuronal cells and mouse brain. Colocalization of COPS5 and RanBP9 in the same subcellular compartments further supported the interaction of both proteins. Furthermore, like RanBP9, COPS5 robustly increased Aβ generation, followed by increased soluble APP-β (sAPP-β) and decreased soluble-APP-α (sAPP-α) levels. Most importantly, down-regulation of COPS5 by siRNAs reduced Aβ generation, implying that endogenous COPS5 regulates Aβ generation. Finally, COPS5 levels were increased significantly in AD brains and APΔE9 transgenic mice, and overexpression of COPS5 strongly increased RanBP9 protein levels by increasing its half-life. Taken together, these results suggest that COPS5 increases Aβ generation by increasing RanBP9 levels. Thus, COPS5 is a novel RanBP9-binding protein that increases APP processing and Aβ generation by stabilizing RanBP9 protein levels.

[1]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[2]  S. Yamanaka,et al.  Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice* , 2004, Journal of Biological Chemistry.

[3]  M. Langlois,et al.  Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors. , 2006, Journal of molecular endocrinology.

[4]  D. Kang,et al.  C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65 , 2008, Journal of cellular and molecular medicine.

[5]  S. Clément,et al.  β- and γ-cytoplasmic actins display distinct distribution and functional diversity , 2009, Journal of Cell Science.

[6]  Long Yu,et al.  Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway. , 2012, Biochemical and biophysical research communications.

[7]  Mark S. Shearman,et al.  Amyloid-β Hypothesis of Alzheimer’s Disease , 1998 .

[8]  Y. M. Lee,et al.  Jab1 Interacts Directly with HIF-1α and Regulates Its Stability* , 2002, The Journal of Biological Chemistry.

[9]  D. Selkoe,et al.  Mutagenesis Identifies New Signals for β-Amyloid Precursor Protein Endocytosis, Turnover, and the Generation of Secreted Fragments, Including Aβ42* , 1999, The Journal of Biological Chemistry.

[10]  Yuzhi Chen,et al.  Amyloid precursor protein modulates β-catenin degradation , 2007, Journal of Neuroinflammation.

[11]  Josephine C. Adams,et al.  Novel role of the muskelin–RanBP9 complex as a nucleocytoplasmic mediator of cell morphology regulation , 2008, The Journal of cell biology.

[12]  Hongjie Wang,et al.  Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice , 2012, PloS one.

[13]  Han-Woong Lee,et al.  Jab1 Mediates Cytoplasmic Localization and Degradation of West Nile Virus Capsid Protein* , 2006, Journal of Biological Chemistry.

[14]  R. Tanzi A brief history of Alzheimer's disease gene discovery. , 2012, Journal of Alzheimer's disease : JAD.

[15]  D. Kang,et al.  A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid‐β peptide generation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  R. Pardi,et al.  Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity , 2000, Nature.

[17]  D. Kang,et al.  Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid β Peptide Generation* , 2009, Journal of Biological Chemistry.

[18]  J. Bernhagen,et al.  Role of CSN5/JAB1 in Wnt/β‐catenin activation in colorectal cancer cells , 2012, FEBS letters.

[19]  G. Bu,et al.  LRP in Amyloid‐β Production and Metabolism , 2006 .

[20]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[21]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[22]  Linus Jönsson,et al.  The worldwide societal costs of dementia: Estimates for 2009 , 2010, Alzheimer's & Dementia.

[23]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[24]  M A Pericak-Vance,et al.  Genome-wide association study of Alzheimer's disease , 2012, Translational Psychiatry.

[25]  R. Kraft,et al.  COP9 signalosome‐specific phosphorylation targets p53 to degradation by the ubiquitin system , 2001, The EMBO journal.

[26]  J. Kato,et al.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 , 1999, Nature.

[27]  O. Perez,et al.  Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1 , 2003, Nature Immunology.

[28]  J. Baik,et al.  Physical Interaction of Jab1 with Human Serotonin 6 G-protein-coupled Receptor and Their Possible Roles in Cell Survival* , 2010, The Journal of Biological Chemistry.

[29]  Hongjie Wang,et al.  Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine , 2013, BMC Medicine.

[30]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[31]  Xuesong Cao,et al.  Jab1 antagonizes TGF‐β signaling by inducing Smad4 degradation , 2002 .

[32]  S. Filipek,et al.  Genetic aspects of Alzheimer's disease. , 2004, Acta neurobiologiae experimentalis.

[33]  C. Gahmberg,et al.  LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion. , 2005, Blood.

[34]  K. Baek,et al.  Diverse roles of the scaffolding protein RanBPM. , 2012, Drug discovery today.

[35]  D. Chamovitz,et al.  JAB1/CSN5 and the COP9 signalosome , 2001, EMBO reports.

[36]  T Nishimoto,et al.  Full-sized RanBPM cDNA encodes a protein possessing a long stretch of proline and glutamine within the N-terminal region, comprising a large protein complex. , 2001, Gene.

[37]  G. Gerlitz,et al.  Novel Functional Features of the LIS-H Domain: Role in Protein Dimerization, Half-Life and Cellular Localization , 2005, Cell cycle.

[38]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[39]  T. Bird Genetic aspects of Alzheimer disease , 2008, Genetics in Medicine.

[40]  D. Kang,et al.  Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  D. Kang,et al.  Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration , 2012, Cell Death and Differentiation.

[42]  E. Friedman,et al.  Serine/Threonine Kinase Mirk/Dyrk1B Is an Inhibitor of Epithelial Cell Migration and Is Negatively Regulated by the Met Adaptor Ran-binding Protein M* , 2003, Journal of Biological Chemistry.

[43]  Regina Berretta,et al.  Unveiling Clusters of RNA Transcript Pairs Associated with Markers of Alzheimer’s Disease Progression , 2012, PloS one.

[44]  F. Claret,et al.  JAB1/CSN5: a new player in cell cycle control and cancer , 2010, Cell Division.

[45]  R. Roos,et al.  Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway , 2012, Neurobiology of Disease.

[46]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[47]  R. Pardi,et al.  RanBPM Is a Phosphoprotein That Associates with the Plasma Membrane and Interacts with the Integrin LFA-1* , 2004, Journal of Biological Chemistry.